Clinical Trial Update: The Effect of Higher Protein Dosing in Critically Ill Patients Ultrasound a Sub-study [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating higher protein dosing in critically ill patients; study withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Malnutrition

Snippet

Sponsor: Clinical Evaluation Research Unit at Kingston General Hospital | Conditions: Critical Illness, Malnutrition | Phase 3 | Status: WITHDRAWN